Ka Shing Li

This profile gathers the share dealings of Ka Shing Li across 2 companies, led by Celsius Holdings, Inc. and Niagen Bioscience, Inc. We count 3 filings; the first trade dates from 14 December 2020 and the latest from 20 August 2024.

The open-market record consists of 2 sales worth €124.3M, with no purchase. No amount is published for 1 filing, which the totals therefore leave out. Since January 2024: no purchases and 1 sale on the market.

On 21 August 2024 came the latest disclosure, an open-market sale in Niagen Bioscience, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.